Results 191 to 193 of about 5,494 (193)

TRAILBLAZER-ALZ 4: A Phase 3 Trial Comparing Donanemab With Aducanumab on Amyloid Plaque Clearance in Early, Symptomatic Alzheimer's Disease

Alzheimer's and Dementia
Emily C Collins, John R Sims, Andrew Pain   +2 more
exaly  

Comparative Efficacy, Tolerability and Acceptability of Donanemab, Lecanemab, Aducanumab and Lithium on Cognitive Function in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Network Meta-Analysis

Ageing Research Reviews
Itsuki Terao, Wakako Kodama
exaly  

Aducanumab (Aduhelm) for Alzheimer's disease.

The Medical letter on drugs and therapeutics, 2021
openaire   +1 more source